Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

04. August 2014 16:05 ET | Quelle: Stereotaxis, Inc.

Stereotaxis Reports 2014 Second Quarter Financial Results

-Achieves Second Consecutive Quarter of Strong Recurring Revenue- -Improves Operating Loss by 16% from First Half of 2013- -Showcases Technologies at Preeminent Industry Events in Target...
28. Juli 2014 06:30 ET | Quelle: Stereotaxis, Inc.

Stereotaxis to Report Second Quarter 2014 Financial Results on August 4, 2014

ST. LOUIS, July 28, 2014 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (Nasdaq:STXS) today announced that it will release financial results for its 2014 second quarter ended June 30, 2014 on Monday, August 4,...
21. Juli 2014 06:30 ET | Quelle: Stereotaxis, Inc.

Stereotaxis to Present Niobe(R) System Technology at Japan Heart Rhythm Society

ST. LOUIS, July 21, 2014 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (Nasdaq:STXS) today announced that it will present at the 29th Annual Meeting of the Japanese Heart Rhythm Society in Tokyo beginning...
16. Juni 2014 06:30 ET | Quelle: Stereotaxis, Inc.

Stereotaxis to Highlight Efficiency, Efficacy and Safety of Its Technology at Cardiostim 2014

ST. LOUIS, June 16, 2014 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (Nasdaq:STXS) today announced that it will participate in Cardiostim 2014, the biennial scientific congress of the European Heart Rhythm...
10. Juni 2014 06:30 ET | Quelle: Stereotaxis, Inc.

Stereotaxis Submits 510(k) Application to FDA for Vdrive(TM) With V-CAS(TM) Catheter Advancement System

ST. LOUIS, June 10, 2014 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (Nasdaq:STXS) announced today that it has submitted a 510(k) Premarket Notification to the Food and Drug Administration (FDA) for the...
06. Mai 2014 16:06 ET | Quelle: Stereotaxis, Inc.

Stereotaxis to Present New Clinical Evidence, Features of Automated Technologies at Heart Rhythm 2014

ST. LOUIS, May 6, 2014 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (Nasdaq:STXS) today announced several firsts for its eleventh appearance at the annual Heart Rhythm Society (HRS) Scientific Sessions, to...
06. Mai 2014 16:05 ET | Quelle: Stereotaxis, Inc.

Stereotaxis Reports 2014 First Quarter Financial Results

-Records $7 Million in Recurring Revenue, Aided by Sequential Procedure Growth- -Furthers Marketing Strategy for Niobe® System in Japan- -Expands Vdrive™ with V-Sono™ System...
30. April 2014 06:30 ET | Quelle: Stereotaxis, Inc.

Stereotaxis to Report First Quarter 2014 Financial Results on May 6, 2014

ST. LOUIS, April 30, 2014 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (Nasdaq:STXS) today announced that it will release financial results for its 2014 first quarter ended March 31, 2014 on Tuesday, May 6,...
01. April 2014 06:30 ET | Quelle: Stereotaxis, Inc.

Stereotaxis Submits 510(k) Application to FDA for Vdrive(TM) with V-Loop(TM) System

ST. LOUIS, April 1, 2014 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (Nasdaq:STXS) announced today that it has submitted a 510(k) Premarket Notification with the Food and Drug Administration (FDA) for the...
31. März 2014 06:30 ET | Quelle: Stereotaxis, Inc.

Stereotaxis Expands Credit Facility With Silicon Valley Bank to $10 Million

ST. LOUIS, March 31, 2014 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (Nasdaq:STXS) announced today that it has entered into an amended credit agreement with Silicon Valley Bank (SVB) that replaces its...

Vorherige Seite